Of 179 cervical cancer specimens, 148 (82.6%) was available to confirm co-expression between HIF-1α and c-Met, 131 (73.1%) was available between HIF-1α and CA9, and 137 (76.5%) was available between HIF-1α and GLUT1 (Table 4). This evidence concerns the gene SLC2A1 and cervical carcinoma.